Detalhe da pesquisa
1.
Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study.
Haematologica
; 100(12): 1579-86, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26430172
2.
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study.
Clin Microbiol Infect
; 30(6): 764-771, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38432433
3.
Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT).
Eur J Haematol
; 90(3): 177-86, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23301689
4.
Vowel production: a potential speech biomarker for early detection of dysarthria in Parkinson's disease.
Front Psychol
; 14: 1129830, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37701868
5.
Physical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial.
JMIR Res Protoc
; 11(11): e40969, 2022 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36427234
6.
Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study.
Blood Adv
; 6(16): 4807-4815, 2022 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772168
7.
Clinical presentation, outcome, and prognostic markers in patients with intravascular large B-cell lymphoma, a lymphoma study association (LYSA) retrospective study.
Cancer Med
; 11(19): 3602-3611, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538643
8.
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network.
Bone Marrow Transplant
; 57(6): 966-974, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35422077
9.
Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.
Leuk Res
; 29(9): 1003-7, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16038726
10.
Efficacy of lenalidomide plus dexamethasone in patients older than 75 years with relapsed multiple myeloma.
Leuk Lymphoma
; 53(7): 1318-20, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22211836
11.
Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients?
Transplantation
; 94(3): 295-301, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22797728